Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Common Equity: 2010-2025

Historic Common Equity for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to -$14.8 million.

  • Cryo Cell International's Common Equity fell 5515.71% to -$14.8 million in Q3 2025 from the same period last year, while for Aug 2025 it was -$14.8 million, marking a year-over-year decrease of 5515.71%. This contributed to the annual value of -$13.2 million for FY2024, which is 1980.54% down from last year.
  • As of Q3 2025, Cryo Cell International's Common Equity stood at -$14.8 million, which was down 5515.71% from -$15.6 million recorded in Q2 2025.
  • Over the past 5 years, Cryo Cell International's Common Equity peaked at $4.8 million during Q3 2021, and registered a low of -$15.6 million during Q2 2025.
  • Over the past 5 years, Cryo Cell International's median Common Equity value was -$1.7 million (recorded in 2021), while the average stood at -$4.5 million.
  • As far as peak fluctuations go, Cryo Cell International's Common Equity skyrocketed by 35079.73% in 2022, and later tumbled by 5904097.63% in 2024.
  • Cryo Cell International's Common Equity (Quarter) stood at $4.2 million in 2021, then tumbled by 136.43% to -$1.5 million in 2022, then tumbled by 623.69% to -$11.0 million in 2023, then dropped by 19.81% to -$13.2 million in 2024, then fell by 12.22% to -$14.8 million in 2025.
  • Its last three reported values are -$14.8 million in Q3 2025, -$15.6 million for Q2 2025, and -$14.7 million during Q1 2025.